Vasculitis, Systemic: Clinical Trials

1 trial for Vasculitis, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Vasculitis, Systemic: new trials by email Literature Review of Vasculitis, Systemic trials Research Report on Vasculitis, Systemic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing
Phase 4Active not recruitingUniversity of Sao Paulo General Hospital20052023-05-232026-05-04

Narrower conditions

Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Behcet Syndrome (1)  ·  Dermatomyositis (1)  ·  Herpes Zoster (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Myositis (1)  ·  Scleroderma, Systemic (1)  ·  Sjogren's Syndrome (1)  ·  Spondylarthritis (1)  ·  Spondylitis, Ankylosing (1)  ·  Systemic Vasculitis (1)

Broader conditions

Ankylosis (1)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Axial Spondyloarthritis (1)  ·  Bone Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  DNA Virus Infections (1)  ·  Dry Eye Syndromes (1)  ·  Eye Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)

Sponsors

University of Sao Paulo General Hospital (1)

Countries

Brazil (1)

Results publications

PMID 41679320, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284